Out Too Soon
My real name is King Julian ;)
- Joined
- 26 March 2006
- Posts
- 664
- Reactions
- 1
Still a great short just waiting for the right moment to reload my short position.
I thought there'd be some retracement but didn't anticipate it to be quite so strong.
Technically it's back to the bottom of the gap down so perhaps that's where the resistance will be. How it close today will be quite important. A more aggressive trade would short now @ 138 with stop at above today's high. Otherwise, wait for more confirmation at breakdown below 135 or so.
Who do you use for your shorts? It's about shorting time & I'm only getting half the fun by only profiting on the upside :1zhelp:
Still a great short just waiting for the right moment to reload my short position.
I thought there'd be some retracement but didn't anticipate it to be quite so strong.
Technically it's back to the bottom of the gap down so perhaps that's where the resistance will be. How it close today will be quite important. A more aggressive trade would short now @ 138 with stop at above today's high. Otherwise, wait for more confirmation at breakdown below 135 or so.
Thanks Notting.I'm buying. It just isn't gonna do its great growth this year due to a couple of contracts going bad.
Good company. Long termer....
good one SystematicAlong with TNE I rated IRI as one of the worst in my most recent look. Doesn't mean it isn't a quality stock - I just don't like anything about the price right now. But that can mean nothing if it's one of 'those' growth stocks (that work out). Either way, I won't be on it!
Sydney, January 10, 2019 - Integrated Research (“IR”) is in the early stages of preparing its half year financial statements for the six months ending 31 December 2018. Based on internal management accounts and subject to audit review, the Company anticipates reporting a strong result for the half-year. Revenue is expected to be in the range of $49.0 million to $50.5 million, representing 7% to 11% of growth over the equivalent prior period. Profit after tax for the half is expected to be in the range of $11.1 million to $11.7 million compared to $9.3 million, representing 19% to 26% growth.
Licence sales are expected to be in the range of $30.0 million to $31.5 million, representing 17% to 23% growth. Pleasingly, the Company’s European operation saw a return to growth for the half with a significant contribution from the Payments product line.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?